Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio is broader than the current focuses on mask production. 

Antony Legge, Executive Chairman of RMS, said; “We are very pleased to update the market (https://www.share-talk.com/remote-monitored-sys-rms-l-update-on-pharm-to-farm-ltd/#gs.unceo9) with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement means P2F can commence sales with confidence as we anticipate a continuing market need for P2F’s proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes.”

https://www.share-talk.com/antony-legge-interim-executive-chairman-remote-monitored-systems-rms-l-interview/

Show Notes

Finally, we got the opportunity to speak with Antony about today company update and ask a few questions we hope shareholders find informative. What is cleary stated, P2F’s company portfolio is broader than the current focuses on mask production. 



Antony Legge, Executive Chairman of RMS, said; “We are very pleased to update the market with the positive developments achieved by the P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement means P2F can commence sales with confidence as we anticipate a continuing market need for P2F’s proprietary α-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes.”

https://www.share-talk.com/antony-legge-interim-executive-chairman-remote-monitored-systems-rms-l-interview/


Listen On

Also Listen